Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Salaheldin, S."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jaleh Fallah, Michael H. Brave, Chana Weinstock, Gautam U. Mehta, Diana Bradford, Haley Gittleman, Erik W. Bloomquist, Rosane Charlab, Salaheldin S. Hamed, Claudia P. Miller, Sarah E. Dorff, Wiley A. Chambers, Bronwyn D. Mixter, Jeannette Dinin, William F. Pierce, Tiffany K. Ricks, Shenghui Tang, Martha Donoghue, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Julia A. Beaver
Publikováno v:
Clin Cancer Res
On August 13, 2021, the FDA approved belzutifan (WELIREG, Merck), a first-in-class hypoxia-inducible factor (HIF) inhibitor for adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d366bff8662137a824aa2634279d526
https://doi.org/10.1158/1078-0432.ccr-22-1054
https://doi.org/10.1158/1078-0432.ccr-22-1054
Autor:
Asma Dilawari, Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah, Salaheldin S. Hamed, Junshan Qiu, Jingyu Yu, Wimolnut Manheng, Tiffany K. Ricks, Rajan Pragani, Arulvathani Arudchandran, Paresma Patel, Shadia Zaman, Arpita Roy, Shyam Kalavar, Soma Ghosh, William F. Pierce, Nam Atiqur. Rahman, Shenghui Tang, Bronwyn D. Mixter, Paul G. Kluetz, Richard Pazdur, Laleh Amiri-Kordestani
Publikováno v:
Clinical Cancer Research.
On November 14, 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to mirvetuximab soravtansine-gynx for treatment of adult patients with folate receptor-α (FRα)-positive, platinum-resistant epithelial ovarian, fallopian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca1f07ed74fcc0324e66e895dd1a7a9a
https://doi.org/10.1158/1078-0432.ccr-23-0991
https://doi.org/10.1158/1078-0432.ccr-23-0991
Autor:
Harpreet Singh, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Atiqur Rahman, John Leighton, Shenghui Tang, Kwadwo Korsah, Rajan Pragani, Rajiv Agarwal, Xing Wang, Whitney S. Helms, Anwar Goheer, Hong Zhao, Jiang Liu, Yangbing Li, Salaheldin S. Hamed, Joyce Cheng, Flora Mulkey, Adnan A. Jaigirdar, Sonia Singh
Supplementary Table 1 shows adverse reactions occurring at a frequency of 10% or higher in patients with SCLC who received lurbinectedin in Study B-005. Supplementary Table 2 shows select laboratory abnormalities as worsening from baseline and occurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c295b53618159c09db07f6457c38c2
https://doi.org/10.1158/1078-0432.22482252
https://doi.org/10.1158/1078-0432.22482252
Data from FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
Autor:
Harpreet Singh, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Atiqur Rahman, John Leighton, Shenghui Tang, Kwadwo Korsah, Rajan Pragani, Rajiv Agarwal, Xing Wang, Whitney S. Helms, Anwar Goheer, Hong Zhao, Jiang Liu, Yangbing Li, Salaheldin S. Hamed, Joyce Cheng, Flora Mulkey, Adnan A. Jaigirdar, Sonia Singh
On June 15, 2020, the FDA granted accelerated approval to lurbinectedin for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. Approval was granted on the ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b446473ac2cba9dfb2984a647d00aaeb
https://doi.org/10.1158/1078-0432.c.6530874
https://doi.org/10.1158/1078-0432.c.6530874
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joyce Cheng, Whitney S. Helms, Adnan A. Jaigirdar, Marc R. Theoret, Kwadwo Korsah, Atiqur Rahman, Julia A. Beaver, Rajiv Agarwal, Salaheldin S. Hamed, Hong Zhao, Harpreet Singh, Anwar Goheer, Yangbing Li, Jiang Liu, Sonia Singh, John K. Leighton, Xing Wang, Richard Pazdur, Shenghui Tang, Flora Mulkey, Rajan Pragani
Publikováno v:
Clin Cancer Res
On June 15, 2020, the FDA granted accelerated approval to lurbinectedin for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. Approval was granted on the ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2c2183870cef2b98c254cad4e07204
https://doi.org/10.1158/1078-0432.ccr-20-3901
https://doi.org/10.1158/1078-0432.ccr-20-3901
Autor:
Salaheldin S. Hamed, Ramana S. Uppoor, Mariam A. Ahmed, Lana Al-Mansour, Bilal S AbuAsal, Mehul Mehta
Publikováno v:
The Journal of Clinical Pharmacology. 60:1441-1452
The development of modified-release (MR) drug products aims to address a clinical need such as improving patient compliance. There are multiple pathways and development strategies for the registration and approval of MR products. The development stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cde8774647633268cb38482fbda90a
https://doi.org/10.1002/jcph.1637
https://doi.org/10.1002/jcph.1637
Autor:
Kirsten B. Goldberg, Lola Fashoyin-Aje, Shenghui Tang, Pengfei Song, Marc R. Theoret, Joyce Cheng, Rosane Charlab, Sakar Wahby, Jeannette Dinin, Laleh Amiri-Kordestani, Mallorie H. Fiero, Tiffany K. Ricks, Salaheldin S. Hamed, Julia A. Beaver, Sarah E. Dorff, Kimberly Barnett-Ringgold, Richard Pazdur, Lijun Zhang, Christy L. Osgood
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(7)
On April 22, 2020, the FDA granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY; Immunomedics, Inc.) for the treatment of patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c689a9ecf8bf916377f5a04c76ee343
https://pubmed.ncbi.nlm.nih.gov/33168656
https://pubmed.ncbi.nlm.nih.gov/33168656